Finasteride Side Effects: How Common Are They and Can They Be Permanent?
Medically reviewed by Dr. Michael Koehler, MD
Finasteride is one of the most widely discussed medications for male pattern hair loss, and much of that discussion centers on side effects.
Searches for finasteride side effects, sexual dysfunction, topical finasteride, long-term effects, and permanent symptoms have increased as more men consider medical treatment for hair loss. Unfortunately, online discussions often fall into two extremes. Some portray finasteride as essentially risk-free, while others suggest that serious or permanent complications are inevitable.
Neither interpretation accurately reflects the evidence.
Finasteride can cause side effects. Sexual adverse effects such as decreased libido, erectile dysfunction, and ejaculation changes are recognized adverse reactions. Postmarketing reports have also described sexual symptoms that continued after treatment was stopped. More recently, European regulators strengthened warnings concerning mood changes and suicidal ideation associated with oral finasteride. At the same time, controlled clinical trials show that most men taking 1 mg finasteride do not report sexual adverse effects, and placebo groups report some of the same symptoms.
Understanding finasteride therefore requires more than asking whether side effects are "real." The more useful questions are:
What are the most common side effects of finasteride?
How common are finasteride sexual side effects?
Are 1 mg and 5 mg finasteride side effects different?
Does topical finasteride have side effects?
Can finasteride side effects continue after stopping treatment?
What does current research say about so-called post-finasteride syndrome?
How might finasteride affect fertility?
What should someone do if side effects develop?
This guide examines those questions using prescribing information, controlled clinical trials, systematic reviews, and current regulatory guidance.
Quick answer: The best-established finasteride side effects involve sexual function, including decreased libido, erectile dysfunction, and ejaculation changes. In the pivotal 1 mg hair-loss trials, 3.8% of men taking finasteride reported one or more drug-related sexual adverse events compared with 2.1% receiving placebo. Persistent sexual symptoms after discontinuation have been reported and are included in U.S. labeling, but postmarketing reports cannot establish how frequently persistent symptoms occur or prove causality in every reported case.
What Is Finasteride?
Finasteride is a 5-alpha-reductase inhibitor. It inhibits the type II form of the 5-alpha-reductase enzyme, which converts testosterone into dihydrotestosterone, commonly abbreviated DHT.
DHT plays an important role in androgen-dependent tissues. In genetically susceptible men, DHT contributes to progressive miniaturization of scalp hair follicles and the development of androgenetic alopecia, better known as male pattern hair loss.
Reducing DHT can slow that process.
Finasteride is also used at a higher dose to treat benign prostatic hyperplasia, or BPH.
In the United States, the typical approved oral doses are:
Finasteride 1 mg: male pattern hair loss.
Finasteride 5 mg: symptomatic benign prostatic hyperplasia in men with an enlarged prostate.
The current U.S. prescribing information for 1 mg finasteride specifies one 1 mg tablet once daily for male pattern hair loss.
This distinction matters when discussing side effects because studies involving finasteride 1 mg for hair loss should not automatically be treated as equivalent to studies of finasteride 5 mg in generally older men with BPH.
How Does Finasteride Work?
Finasteride does not simply "lower testosterone."
Its primary action is reducing the conversion of testosterone to DHT.
This distinction is important because people sometimes assume that sexual side effects occur because finasteride causes testosterone deficiency. That is an oversimplification.
Finasteride changes androgen metabolism by inhibiting 5-alpha reductase and reducing DHT. The biological consequences of that change can differ among tissues and individuals.
DHT suppression is also the reason finasteride can help slow androgen-dependent hair follicle miniaturization.
The same mechanism that produces the intended therapeutic effect is relevant when evaluating potential adverse effects.
What Are the Side Effects of Finasteride?
The best-established side effects of finasteride are related to sexual and reproductive function.
For oral finasteride, reported or recognized adverse effects include:
decreased libido
erectile dysfunction
ejaculation disorders
decreased ejaculate volume
orgasm disorders reported postmarketing
breast tenderness or enlargement
testicular pain reported postmarketing
reduced semen quality or male infertility reports
depression
suicidal ideation and behavior
hypersensitivity reactions such as rash, itching, hives, and angioedema
Postmarketing reports have also included male breast cancer, although the relationship between long-term finasteride exposure and male breast neoplasia remains uncertain.
It is important to distinguish clinical-trial incidence data from postmarketing reports.
Clinical trials can estimate how frequently specific events occurred in carefully defined treatment and placebo groups.
Postmarketing surveillance is different. People and healthcare professionals voluntarily report suspected adverse events after a medication reaches the market. These reports can identify important safety signals, but because the total exposed population and other relevant variables are often uncertain, they usually cannot provide a reliable incidence percentage or prove that the drug caused every reported event.
That distinction becomes particularly important when discussing persistent finasteride side effects.
Finasteride Sexual Side Effects
Sexual adverse effects are the most frequently discussed finasteride side effects in men.
They include three major categories:
Decreased libido
Some men report reduced sexual desire or interest while taking finasteride.
Erectile dysfunction
Some report difficulty achieving or maintaining an erection.
Ejaculatory changes
These can include reduced ejaculate volume or other ejaculation disorders.
These effects are recognized in official prescribing information rather than existing solely as anecdotal reports online.
The more difficult question is how frequently they occur.
How Common Are Finasteride Side Effects?
This is where actual percentages are particularly useful.
In three controlled 12-month clinical trials of finasteride 1 mg for male pattern hair loss, 945 men received finasteride and 934 received placebo.
During the first year:
Decreased libido:
1.8% with finasteride versus 1.3% with placebo.
Erectile dysfunction:
1.3% versus 0.7%.
Ejaculation disorder:
1.2% versus 0.7%.
Decreased ejaculate volume:
0.8% versus 0.4%.
Overall, 3.8% of men receiving finasteride reported one or more of these drug-related sexual adverse events compared with 2.1% receiving placebo.
That is one of the most useful numbers for answering the question, "How common are finasteride side effects?"
It shows two things simultaneously.
First, sexual adverse effects occurred more frequently with finasteride than placebo.
Second, the overwhelming majority of men in these trials did not report one of these sexual adverse effects.
Both points matter.
Saying that sexual side effects are imaginary would contradict the evidence.
Saying that most men taking 1 mg finasteride develop sexual dysfunction would also contradict these controlled trial data.
Understanding Finasteride Side Effects Percentage
Percentages need context.
For example, erectile dysfunction occurred in:
1.3% of finasteride-treated participants
0.7% of placebo-treated participants
The absolute difference was therefore approximately 0.6 percentage points in these trials.
For decreased libido:
1.8% with finasteride
1.3% with placebo
The absolute difference was approximately 0.5 percentage points.
This does not mean that every real-world population will experience exactly these percentages. Clinical-trial participants may differ from people receiving treatment in routine medical practice.
It does illustrate why relative-risk statistics should not be interpreted without absolute risk.
A systematic review and meta-analysis of 15 randomized, double-blind, placebo-controlled trials involving 4,495 participants found that 5-alpha-reductase inhibitors used for male androgenetic alopecia were associated with a higher relative risk of sexual dysfunction. For finasteride specifically, the reported relative risk was 1.66.
A relative increase can sound dramatic without knowing the underlying absolute event rate.
For informed decision-making, both are useful.
Do Finasteride Sexual Side Effects Improve?
In the pivotal 1 mg clinical trials, sexual adverse effects resolved in men who discontinued treatment because of them and in most men who continued therapy despite experiencing them.
The incidence of each specified sexual adverse event also decreased to 0.3% or less by the fifth year among participants remaining in the clinical program.
That is reassuring, but it does not mean persistent symptoms never occur.
Postmarketing experience has produced reports of sexual dysfunction continuing after discontinuation. U.S. labeling specifically includes continuing erectile dysfunction, libido disorders, ejaculation disorders, and orgasm disorders among postmarketing adverse reactions.
The evidence therefore requires a nuanced interpretation:
Many treatment-emergent sexual adverse effects resolve, but persistent symptoms after stopping finasteride have also been reported.
Can Finasteride Side Effects Be Permanent?
This is one of the most searched and most controversial questions surrounding the medication.
The most accurate answer is:
Persistent sexual, reproductive, and neuropsychiatric symptoms after finasteride discontinuation have been reported, but the available evidence does not allow us to determine precisely how often persistent symptoms occur or establish finasteride as the cause of every reported persistent symptom.
Current U.S. labeling lists postmarketing reports of sexual dysfunction continuing after treatment was discontinued, including:
erectile dysfunction
libido disorders
ejaculation disorders
orgasm disorders
It also lists male infertility and poor seminal quality, with normalization or improvement in semen quality reported after discontinuation in some cases.
The key phrase is postmarketing reports.
Because these reports arise from a population of uncertain size and are voluntarily submitted, the labeling explicitly notes that it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Therefore, claims such as "finasteride permanent side effects happen to X% of users" should be treated cautiously unless the percentage comes from an appropriately designed study that actually measured persistent symptoms.
What Is Post-Finasteride Syndrome?
The term post-finasteride syndrome, often abbreviated PFS, is commonly used to describe a collection of sexual, physical, and psychological symptoms reported by some people after stopping finasteride.
Reported symptoms may include persistent changes in:
libido
erectile function
ejaculation
orgasm
mood
cognition
energy
emotional well-being
The existence of people reporting persistent symptoms should not be dismissed.
At the same time, a syndrome label is not the same thing as having a fully established mechanism, prevalence, diagnostic test, or proven causal pathway.
Persistent symptoms are difficult to study because erectile dysfunction, decreased libido, depression, anxiety, fatigue, and cognitive complaints can occur independently of finasteride and can have multiple contributing factors.
Good medical evaluation therefore requires more than assuming either:
"Finasteride definitely caused every symptom"
or
"Finasteride could not possibly have contributed."
Neither approach adequately reflects the uncertainty.
Long-Term Side Effects of Finasteride
People searching for long-term side effects of finasteride are often asking two different questions:
Does taking finasteride for years cause progressively increasing adverse effects?
Can adverse effects continue after the medication is discontinued?
Those are not the same question.
In long-term clinical data from 1 mg finasteride studies, new reports of the specified sexual adverse effects decreased over time rather than progressively increasing.
Similarly, in the 5 mg BPH data, the prescribing information reports that sexual adverse experiences did not increase with increasing duration of therapy, and rates of impotence and decreased libido were not significantly different between treatment groups during combined years two through four.
However, these observations do not eliminate the separate issue of postmarketing reports of persistent symptoms after discontinuation.
"Long-term use" and "persistent symptoms after stopping" should therefore not be used interchangeably.
Finasteride 1 mg Side Effects
For hair loss, finasteride 1 mg side effects are particularly relevant because 1 mg once daily is the approved U.S. oral dosage for male pattern hair loss.
The pivotal first-year data showed:
decreased libido: 1.8%
erectile dysfunction: 1.3%
ejaculation disorder: 1.2%
decreased ejaculate volume: 0.8%
One or more drug-related sexual adverse events occurred in 3.8% of finasteride users compared with 2.1% receiving placebo.
Discontinuation specifically because of drug-related sexual adverse experiences occurred in 1.2% of finasteride users and 0.9% of placebo users.
These numbers provide a much more useful perspective than simply labeling sexual side effects "common" or "rare."
Finasteride 5 mg Side Effects
Finasteride 5 mg is used for BPH rather than the standard treatment of male pattern hair loss.
Side-effect percentages in 5 mg BPH studies were higher than those reported in the 1 mg hair-loss trials, particularly during the first year.
In a four-year placebo-controlled BPH study, first-year adverse events included:
Impotence: 8.1% finasteride versus 3.7% placebo.
Decreased libido: 6.4% versus 3.4%.
Decreased ejaculate volume: 3.7% versus 0.8%.
Ejaculation disorder: 0.8% versus 0.1%.
Breast enlargement: 0.5% versus 0.1%.
Breast tenderness: 0.4% versus 0.1%.
But there is an important caveat.
You cannot conclude from these numbers alone that taking 5 mg instead of 1 mg makes an individual man's risk of erectile dysfunction increase from 1.3% to 8.1%.
These were different clinical trials involving different patient populations and indications. The BPH population generally consisted of older men, and age itself affects baseline erectile function, libido, prostate health, medication use, and other variables.
Cross-trial percentages are not a substitute for a head-to-head dose comparison.
Does a Higher Finasteride Dose Mean More Side Effects?
It is biologically reasonable to ask whether higher exposure could influence adverse effects, but the relationship is not as simple as multiplying the dose.
The 1 mg and 5 mg trial percentages should not be directly compared as if they came from identical populations randomly assigned to those two doses for the same condition.
The practical point is straightforward:
Use the dose appropriate for the condition and prescribed by a qualified clinician.
Taking more finasteride than prescribed does not make hair grow proportionally faster, and patients should not independently alter dosing in an attempt to balance efficacy and side effects.
Topical Finasteride Side Effects
Topical finasteride has become increasingly popular because it is intended to deliver finasteride to the scalp while reducing systemic exposure.
But "topical" does not mean "zero systemic absorption."
A phase III randomized controlled trial involving adult men with androgenetic alopecia compared topical finasteride, placebo, and oral finasteride.
At 24 weeks, topical finasteride improved hair count compared with placebo. Importantly for safety, maximum plasma finasteride concentrations were more than 100 times lower with topical treatment than with oral finasteride.
Mean serum DHT decreased by approximately:
34.5% with topical finasteride
versus
55.6% with oral finasteride.
The incidence and type of adverse events did not meaningfully differ between topical finasteride and placebo in that study.
These findings support the idea that topical delivery can reduce systemic exposure.
They do not prove that topical finasteride cannot produce systemic side effects.
Does Topical Finasteride Have Side Effects?
Yes, it can.
Topical finasteride can produce local adverse effects related to scalp application, and some amount of finasteride can enter systemic circulation.
The phase III data are encouraging because systemic exposure was substantially lower than with oral finasteride, but serum DHT still declined.
Therefore, it is inaccurate to say:
"Topical finasteride has no sexual side effects."
A better conclusion is:
Topical finasteride may reduce systemic exposure compared with oral finasteride, but it does not necessarily eliminate systemic exposure or the possibility of systemic adverse effects.
The exact risk can also depend on formulation, concentration, application amount, frequency, scalp condition, and other variables. Not every compounded topical finasteride product is equivalent to the specific formulation tested in a clinical trial.
Oral Finasteride Side Effects vs. Topical Finasteride Side Effects
For someone worried about systemic effects, topical treatment may appear attractive.
The evidence supports lower systemic exposure with at least some studied topical formulations.
However, treatment decisions should account for more than whether a medication is swallowed or applied to the scalp.
Considerations include:
strength
formulation
dose delivered
application frequency
evidence supporting the specific product
systemic absorption
individual risk factors
treatment goals
tolerance
"Topical" should not automatically be translated into "risk-free."
Likewise, oral finasteride should not automatically be assumed to cause adverse effects in every patient.
Finasteride and Minoxidil Side Effects
Finasteride and minoxidil are often discussed together because they target hair loss through different mechanisms.
Finasteride reduces DHT formation.
Minoxidil works through a different pathway and does not inhibit 5-alpha reductase.
As a result, finasteride and minoxidil side effects should not simply be combined into one list.
Finasteride is more closely associated with potential sexual adverse effects.
Topical minoxidil is more commonly associated with effects such as:
scalp irritation
itching
dryness
unwanted facial or body hair growth
temporary increased shedding after initiation in some patients
Systemic effects from minoxidil require separate consideration, particularly with oral minoxidil.
When someone develops a new symptom while using combination therapy, determining which medication is responsible may be difficult.
That is one reason it can be useful for clinicians to know exactly when each treatment was started, the formulation used, and when symptoms appeared.
Affinity has separately reviewed the evidence surrounding low-dose oral minoxidil for healthier hair, including its potential benefits and safety considerations.
Can Finasteride Cause Erectile Dysfunction?
Yes.
Erectile dysfunction is a recognized adverse reaction to finasteride.
In the pivotal 1 mg hair-loss trials, erectile dysfunction was reported as drug-related in 1.3% of men receiving finasteride compared with 0.7% receiving placebo during the first year.
However, developing erectile dysfunction while taking finasteride does not automatically prove finasteride is the sole cause.
Erectile function is influenced by:
cardiovascular health
blood pressure
medications
testosterone status
diabetes
neurologic disease
smoking
alcohol
sleep
stress
depression
anxiety
relationship factors
age
A man developing erectile dysfunction during finasteride treatment may therefore benefit from a broader medical assessment rather than assuming the medication explains everything.
This is especially important if symptoms persist.
Men concerned about erectile function can also learn more about erectile dysfunction treatment and the importance of identifying the underlying cause rather than treating every case as identical.
Can Finasteride Lower Libido?
Yes.
Reduced libido is another established finasteride adverse effect.
In first-year trials of 1 mg finasteride, decreased libido was reported in 1.8% of men receiving finasteride versus 1.3% receiving placebo.
Libido is particularly complicated because it is influenced by biological, psychological, relational, and environmental factors.
Low sexual desire can also be associated with:
testosterone deficiency
depression
anxiety
sleep deprivation
chronic illness
medications
relationship stress
significant calorie restriction
substance use
A new change in libido after beginning finasteride deserves attention, but it should still be evaluated in clinical context.
Does Finasteride Lower Testosterone?
Finasteride's principal mechanism is not suppression of testosterone production.
It inhibits conversion of testosterone to DHT.
That distinction matters when evaluating symptoms such as low libido or erectile dysfunction.
Someone experiencing sexual symptoms while taking finasteride should not automatically assume they have low testosterone.
Likewise, testosterone therapy should not automatically be used as an antidote to finasteride-associated sexual symptoms.
Testosterone replacement therapy is intended for appropriately evaluated men with symptoms and biochemical evidence consistent with testosterone deficiency. It is not a universal treatment for erectile dysfunction or medication-related sexual symptoms.
Finasteride and Ejaculation Side Effects
Finasteride can affect ejaculation and semen volume.
In the 1 mg clinical trials, ejaculation disorder occurred in 1.2% of finasteride-treated men versus 0.7% receiving placebo. Decreased ejaculate volume was reported in 0.8% versus 0.4%, respectively.
A separate study cited in prescribing information found a median decrease in ejaculate volume of 0.3 mL after 48 weeks with 1 mg finasteride compared with 0.2 mL with placebo.
This is not the same as saying a man is infertile.
Semen volume, sperm concentration, total sperm count, motility, morphology, and fertility are related but distinct measures.
Does Finasteride Affect Male Fertility?
Finasteride may affect semen parameters in some men.
U.S. postmarketing information includes reports of male infertility and/or poor seminal quality, while also noting that normalization or improvement in seminal quality has been reported after stopping finasteride.
One study examining men presenting for male fertility evaluation found that even low-dose finasteride may reduce sperm counts in some men. For most affected men in that population, sperm counts improved substantially after discontinuation. The investigators advised caution in men desiring fertility, particularly those with oligospermia.
This does not mean that every man taking finasteride becomes infertile.
It does mean fertility goals are relevant when deciding whether and how to use the medication.
A man who is:
actively trying to conceive
known to have low sperm counts
undergoing fertility treatment
experiencing unexplained infertility
should discuss finasteride use with the clinician managing his fertility.
Finasteride Side Effects and Semen Quality
Semen changes are not necessarily permanent.
The available evidence includes cases in which semen parameters improved after finasteride was discontinued.
However, a semen analysis is much more useful than guessing based on ejaculate volume.
A lower amount of visible semen does not necessarily mean a proportionate reduction in sperm count.
Conversely, normal ejaculate volume does not guarantee normal fertility.
Men with fertility concerns should be evaluated appropriately rather than relying on appearance alone.
Finasteride Side Effects and Mood
Finasteride safety discussions increasingly include potential psychiatric effects.
Current U.S. postmarketing information lists:
depression
suicidal ideation
suicidal behavior
among reported nervous system and psychiatric adverse reactions.
Regulatory authorities in Europe conducted an extensive review of finasteride and dutasteride safety and strengthened recommendations in 2025.
The European Medicines Agency concluded that suicidal ideation should be recognized as an adverse effect of oral finasteride 1 mg and 5 mg, although the available data did not allow regulators to estimate its frequency. Most reported cases involved people taking 1 mg finasteride for androgenetic alopecia.
The EMA simultaneously concluded that the benefits of finasteride continued to outweigh the risks for its approved uses.
That balance is important.
The regulatory update should not be minimized, but it also should not be interpreted as evidence that suicidal thoughts are common among finasteride users.
The frequency is currently unknown.
What Should You Do if Finasteride Causes Depression or Mood Changes?
Mood changes deserve prompt attention.
The EMA advises patients using oral finasteride 1 mg for androgenetic alopecia to stop treatment and seek medical advice if they develop depressed mood, depression, or suicidal ideation.
Anyone experiencing suicidal thoughts or an immediate risk of self-harm should seek urgent emergency or crisis support rather than waiting for a routine appointment.
This is one area where "wait and see" is inappropriate.
Why Are Sexual Side Effects Mentioned in the Mood Warning?
European regulators noted that sexual dysfunction may contribute to mood alterations, including suicidal ideation, in some patients using oral finasteride for androgenetic alopecia.
The updated European recommendations therefore advise people taking 1 mg oral finasteride to seek medical advice if sexual dysfunction develops, and clinicians are advised to consider discontinuation.
This does not establish that sexual dysfunction inevitably causes depression or suicidal thoughts.
It recognizes a possible clinically important relationship in some patients.
Finasteride Side Effects in Women
The phrase finasteride side effects in women requires especially careful discussion because the U.S. 1 mg product is indicated for male pattern hair loss in men, not women.
Current U.S. labeling states that finasteride is not indicated for use in women.
The most serious concern involves pregnancy.
Finasteride inhibits conversion of testosterone to DHT, and DHT is required for normal development of male external genitalia.
Because of this mechanism, finasteride is contraindicated during pregnancy because exposure may cause abnormalities of the external genitalia in a male fetus.
Women who are pregnant or may become pregnant should not handle crushed or broken finasteride tablets.
Intact tablets are coated, which prevents contact with the active ingredient during normal handling.
Can Women Ever Be Prescribed Finasteride?
Finasteride has been studied and used off-label in selected women for hair disorders, particularly in specialist dermatology settings.
However, that is different from an FDA-approved indication.
Any discussion of finasteride for women must account for:
pregnancy potential
contraception
reproductive plans
age
type of hair loss
other causes of alopecia
individual medical history
Women should not self-treat hair loss with another person's finasteride prescription.
Female-pattern hair loss also has multiple potential contributing factors, and treatment should begin with an appropriate diagnosis.
Breast-Related Side Effects of Finasteride
Breast tenderness and enlargement have been reported with finasteride.
In the 5 mg BPH trial, breast enlargement occurred in 0.5% of finasteride users versus 0.1% receiving placebo during year one. Breast tenderness occurred in 0.4% versus 0.1%.
Breast changes deserve medical evaluation, particularly:
a new lump
nipple discharge
persistent focal pain
significant enlargement
asymmetry
Male breast cancer has been reported postmarketing, but current labeling states that the relationship between long-term finasteride use and male breast neoplasia is unknown.
A breast lump should therefore not be ignored, but it also should not automatically be assumed to be cancer caused by finasteride.
Allergic Reactions to Finasteride
Hypersensitivity reactions have been reported.
These include:
rash
itching
hives
angioedema
swelling involving the lips, tongue, throat, or face
Swelling affecting the mouth, tongue, or throat can become an emergency if breathing is compromised.
Such symptoms require prompt medical attention.
Testicular Pain and Finasteride
Testicular pain has been reported during postmarketing use of finasteride.
However, testicular pain has many possible causes, some of which require urgent treatment.
Sudden severe testicular pain, swelling, nausea, or a high-riding testicle should not simply be attributed to medication. Conditions such as testicular torsion require emergency evaluation.
Persistent testicular discomfort should also be assessed medically.
Does Finasteride Affect PSA?
Yes.
Finasteride can reduce prostate-specific antigen, or PSA.
This matters because PSA is used in prostate evaluation and cancer screening.
Current prescribing information notes that 1 mg finasteride reduced mean serum PSA in younger men in clinical studies, while 5 mg finasteride in older men with BPH reduces PSA by approximately 50%.
Men undergoing PSA testing should tell their healthcare provider that they take finasteride.
A PSA result should be interpreted with the medication in mind.
A confirmed increase from the lowest PSA achieved during treatment also deserves evaluation, even when the absolute value remains within the usual reference range for men who are not taking a 5-alpha-reductase inhibitor.
Finasteride and Prostate Cancer Risk
This issue is frequently misunderstood.
In the Prostate Cancer Prevention Trial, men receiving finasteride 5 mg had a higher observed incidence of Gleason score 8 to 10 prostate cancers than men receiving placebo, 1.8% versus 1.1%.
Current labeling states that the clinical significance of this finding is unknown. Finasteride 5 mg is not approved for reducing the risk of developing prostate cancer.
This should not be converted into the simplistic statement:
"Finasteride causes aggressive prostate cancer."
Nor should the finding be ignored.
The appropriate interpretation requires understanding the trial design, prostate-volume effects, cancer detection, grading, and subsequent analyses.
For a hair-loss article, the key practical point is that patients should tell clinicians they take finasteride when PSA and prostate health are being evaluated.
Are Finasteride Side Effects Different in Younger and Older Men?
Age can complicate interpretation.
Younger men taking 1 mg finasteride for hair loss generally have a lower baseline prevalence of erectile dysfunction and BPH than older men taking 5 mg finasteride.
That is one reason percentages from 1 mg hair-loss studies and 5 mg BPH studies should not be directly compared.
Age also affects:
testosterone levels
vascular health
medication burden
prostate health
erectile function
fertility goals
A 25-year-old taking finasteride for hair loss and a 70-year-old taking 5 mg for BPH represent substantially different clinical populations.
How Soon Can Finasteride Side Effects Start?
There is no single timeline that applies to every patient.
Side effects may emerge after treatment begins, but symptoms developing months or years later require broader consideration because many health variables can change during that time.
The timing of symptoms can help a clinician evaluate causality, but timing alone does not prove it.
Useful questions include:
When was finasteride started?
What dose was used?
When did symptoms begin?
Did anything else change at the same time?
Were other medications started?
Was there a change in mood, sleep, stress, or relationship health?
Were there changes in testosterone or other hormones?
Did symptoms improve when treatment was discontinued?
Did they recur after restarting?
A careful timeline is often more useful than simply asking whether a symptom appears on a list of possible side effects.
How Long Do Finasteride Side Effects Last?
There is no universal answer.
In controlled trials, sexual adverse events resolved in men who discontinued because of those symptoms and in most participants who continued treatment.
However, postmarketing reports describe sexual symptoms continuing after discontinuation.
Therefore, neither of these statements is appropriate:
"All finasteride side effects disappear immediately when you stop."
"Once you get a finasteride side effect, it will be permanent."
The available evidence supports neither extreme.
How to Reduce Side Effects of Finasteride
People often search for supplements, altered schedules, or other medications that supposedly eliminate finasteride adverse effects.
There is no universally proven "finasteride side-effect prevention stack."
A safer approach begins before treatment.
Confirm the diagnosis
Not every case of hair loss is androgenetic alopecia.
Hair shedding can result from:
telogen effluvium
thyroid disease
iron deficiency
nutritional deficiencies
autoimmune alopecia
medications
significant weight loss
illness
scalp disorders
Using finasteride for the wrong diagnosis exposes someone to risk without addressing the actual cause.
Review baseline symptoms
It can be useful to know whether erectile dysfunction, reduced libido, fertility concerns, depression, or anxiety existed before treatment.
Otherwise, symptoms that predated finasteride may later be incorrectly attributed to it.
Discuss fertility goals
Men trying to conceive or known to have low sperm counts should discuss those issues before starting finasteride.
Use medication as prescribed
Do not increase the dose in an attempt to accelerate hair growth.
Report meaningful changes
New sexual dysfunction, breast changes, mood changes, or other concerning symptoms deserve medical discussion.
Do not self-treat side effects with hormones
Starting testosterone, estrogen blockers, supplements, or erectile dysfunction drugs without understanding the underlying problem can complicate the picture.
Should You Lower the Finasteride Dose if Side Effects Occur?
Dose adjustment is sometimes discussed in clinical practice, but patients should not independently change prescription dosing based on internet advice.
Whether changing the dose makes sense depends on:
indication
severity of symptoms
treatment response
formulation
medical history
alternatives
There is also a difference between what is biologically plausible and what has been proven in controlled trials.
The safest recommendation is to discuss new adverse effects with the prescribing clinician and make an individualized decision.
Should You Stop Finasteride if You Develop Sexual Side Effects?
Not every mild adverse effect automatically requires immediate discontinuation, but sexual symptoms should not be dismissed.
The decision depends on symptom severity, patient preference, treatment goals, and clinical context.
Current European guidance is particularly important here. For patients taking 1 mg oral finasteride for androgenetic alopecia, healthcare professionals are advised to inform patients to seek medical advice if sexual dysfunction occurs and to consider discontinuation.
If depression, depressed mood, or suicidal ideation develops while taking oral finasteride 1 mg for hair loss, EMA guidance advises stopping treatment and seeking medical advice.
Can Supplements Prevent Finasteride Side Effects?
There is no supplement proven to reliably prevent finasteride sexual or psychiatric adverse effects.
Claims that zinc, DIM, herbal testosterone boosters, DHEA, pregnenolone, or other products can "balance hormones" and eliminate finasteride side effects should be treated cautiously.
Adding multiple supplements can also create new side effects and make it more difficult to determine the original cause of symptoms.
If symptoms suggest a hormonal problem, appropriate testing and clinical evaluation are more informative than supplement experimentation.
Can Testosterone Therapy Fix Finasteride Side Effects?
Not automatically.
Finasteride inhibits conversion of testosterone to DHT. It does not simply produce conventional testosterone deficiency.
TRT is therefore not a general antidote to finasteride.
Men with symptoms of testosterone deficiency should be appropriately evaluated. If testing confirms hypogonadism and the clinical picture supports treatment, testosterone replacement therapy may be considered for that separate indication.
But using testosterone simply because a man develops low libido or erectile dysfunction while taking finasteride risks treating the wrong problem.
Finasteride vs. Dutasteride Side Effects
Finasteride and dutasteride are both 5-alpha-reductase inhibitors, but they are not identical.
Finasteride primarily inhibits type II 5-alpha reductase.
Dutasteride inhibits both type I and type II enzymes and generally produces more extensive DHT suppression.
A meta-analysis of randomized trials comparing the medications for androgenetic alopecia found no statistically significant differences between dutasteride and finasteride in altered libido, erectile dysfunction, or ejaculation disorders, although the evidence base was limited.
A more recent systematic review similarly reported no significant overall difference in adverse events between the medications in the included studies.
That does not establish identical long-term safety.
Dutasteride has different pharmacology, greater DHT suppression, and a much longer half-life.
The two medications should not be treated as interchangeable simply because they belong to the same drug class.
Is Dutasteride Safer Than Finasteride?
Current evidence does not justify declaring dutasteride categorically safer.
European regulators reviewing suicidal ideation found insufficient evidence to establish a causal link with dutasteride, whereas suicidal ideation was confirmed as an adverse effect of oral finasteride in the EU review.
However, because the drugs share a mechanism, mood-change information was also added to dutasteride product information as a precaution.
Absence of proof of a particular association is not proof that one medication is universally safer.
Finasteride Side Effects vs. the Nocebo Effect
The nocebo effect is sometimes raised in discussions about finasteride.
A nocebo effect occurs when negative expectations contribute to the perception or reporting of symptoms.
This is a legitimate phenomenon in medicine, but it should not be misused.
The existence of nocebo effects does not mean finasteride adverse effects are imaginary.
Randomized placebo-controlled trials demonstrate differences in sexual adverse events between finasteride and placebo groups.
At the same time, placebo groups also report sexual symptoms.
That tells us sexual function is influenced by many factors and that symptoms occurring during treatment cannot automatically be attributed to the medication.
The appropriate conclusion is not "it's all psychological."
It is that both pharmacologic effects and background/nocebo effects can influence reported symptoms.
Why Online Finasteride Reviews Can Be Misleading
Internet reviews can provide valuable information about individual experiences, but they cannot establish incidence.
People who have an unusually positive or negative experience may be more motivated to post about it.
Online communities can therefore overrepresent extremes.
Someone reading 100 stories of severe adverse effects cannot conclude that 100 out of 100 typical users experience those effects.
Likewise, thousands of positive reviews do not prove a drug is risk-free.
Clinical trials, systematic reviews, pharmacovigilance data, and regulatory assessments answer different questions than online testimonials.
Both patient experiences and controlled evidence matter, but they should not be confused.
What Are the Serious Side Effects of Finasteride?
Serious or potentially important symptoms that deserve prompt attention include:
depressed mood or depression
suicidal thoughts
severe or persistent sexual dysfunction
significant breast changes
allergic swelling of the face, lips, tongue, or throat
significant fertility concerns
persistent testicular symptoms
Emergency symptoms such as difficulty breathing from swelling or immediate risk of self-harm require urgent care.
Men taking finasteride should also tell clinicians about the medication before PSA interpretation.
When Should You Contact a Healthcare Provider?
Contact your healthcare provider if you develop new or concerning symptoms after beginning finasteride, particularly:
significant decrease in libido
erectile dysfunction
ejaculation or orgasm changes
depression or major mood changes
breast enlargement, lump, pain, or nipple discharge
fertility concerns
testicular pain
allergic symptoms
The purpose of evaluation is not simply to decide whether finasteride is "good" or "bad."
It is to determine what is happening and whether continuing treatment remains appropriate for that individual.
When Are Finasteride Side Effects an Emergency?
Seek urgent medical attention for symptoms such as:
suicidal thoughts or imminent self-harm risk
severe facial or throat swelling
difficulty breathing
sudden severe testicular pain
other rapidly progressive or severe symptoms
These should not wait for a routine hair-loss follow-up appointment.
Finasteride Side Effects in Men With Existing Erectile Dysfunction
Men with pre-existing erectile dysfunction deserve individualized consideration.
If erectile function is already impaired, it may be difficult to distinguish medication-related changes from progression of the underlying problem.
Establishing baseline sexual function before treatment can therefore be useful.
ED can also be an early marker of vascular or metabolic health problems.
Rather than assuming every case is hormonal, comprehensive evaluation may consider cardiovascular risk factors, medications, sleep, testosterone status, and other potential causes.
Affinity Whole Health provides erectile dysfunction treatment focused on identifying contributing factors and determining appropriate treatment rather than assuming every case of ED has the same cause.
Finasteride Side Effects and Testosterone Levels
Men sometimes assume that sexual symptoms during finasteride treatment mean they need testosterone testing.
Testing may be appropriate when the broader clinical picture suggests testosterone deficiency, but it should not be reflexive.
Symptoms associated with low testosterone overlap with many other conditions.
They can include:
reduced libido
fatigue
reduced strength
erectile changes
depressed mood
changes in body composition
Diagnosis of hypogonadism requires more than symptoms alone.
If testosterone deficiency is suspected, a clinician may evaluate total testosterone and, depending on the circumstances, free testosterone, SHBG, LH, FSH, prolactin, and other relevant markers.
Affinity's guide to primary and secondary hypogonadism explains why identifying the underlying cause matters before selecting treatment.
Finasteride and Hair Loss Treatment Decisions
Finasteride can be effective for appropriately selected men with androgenetic alopecia, but treatment decisions should consider both expected benefits and potential harms.
A reasonable decision process asks:
How significant is the hair loss?
How much does it affect quality of life?
Is androgenetic alopecia actually the diagnosis?
What is the expected benefit?
What adverse effects matter most to the patient?
Are there fertility plans?
Is there a history of sexual dysfunction?
Is there a history of depression or significant mood symptoms?
Are there alternative treatments?
These questions are more useful than asking whether finasteride is universally "safe" or "dangerous."
Medical treatments rarely fit into such binary categories.
What About Minoxidil Instead of Finasteride?
Minoxidil represents a different treatment approach because it does not inhibit DHT.
For someone who does not want to use a 5-alpha-reductase inhibitor, minoxidil may be discussed with a healthcare provider depending on the type of hair loss.
Topical and oral minoxidil also have their own adverse-effect profiles.
Topical treatment commonly causes local scalp issues.
Low-dose oral minoxidil can produce systemic effects and requires individualized medical consideration.
Affinity has previously reviewed low-dose oral minoxidil for healthier hair: what recent studies and clinical guidelines show for readers interested in that alternative approach.
Do Finasteride Side Effects Always Mean the Medication Caused Them?
No.
This is one of the most important concepts in medication safety.
If 1,000 men take a medication for several years, some will develop:
erectile dysfunction
depression
fertility problems
testicular pain
decreased libido
fatigue
even if the medication has nothing to do with those symptoms.
The challenge is determining whether the rate is higher among exposed people and whether other evidence supports causality.
Randomized trials are particularly useful because treatment and placebo groups can be compared.
Postmarketing reports are useful for identifying events that may be too uncommon, delayed, or complex to emerge clearly during preapproval trials.
Neither form of evidence should be used alone to answer every safety question.
Association Does Not Always Equal Causation
This is especially important with persistent symptoms.
A symptom beginning after a medication was started establishes a temporal relationship.
It does not automatically establish causality.
On the other hand, the inability to prove causality in an individual case does not mean the symptom should be dismissed.
High-quality medical reasoning considers:
timing
biological plausibility
controlled evidence
dose/exposure
alternative explanations
dechallenge response
rechallenge response when available
consistency across data sources
This balanced approach is particularly important for medications such as finasteride, where public discussion is often polarized.
FAQs About Finasteride Side Effects
What are the most common side effects of finasteride?
The best-established side effects of oral finasteride include decreased libido, erectile dysfunction, and ejaculation changes. Other reported effects include breast tenderness or enlargement, mood changes, allergic reactions, testicular pain, and changes in semen quality.
How common are finasteride side effects?
In controlled trials of finasteride 1 mg for male pattern hair loss, 3.8% of men reported one or more drug-related sexual adverse events compared with 2.1% receiving placebo. Individual first-year rates were 1.8% for decreased libido, 1.3% for erectile dysfunction, and 1.2% for ejaculation disorder.
What percentage of men get sexual side effects from finasteride?
The percentage depends on how sexual dysfunction is defined, the study population, dose, and study design. In pivotal 1 mg trials, 3.8% reported one or more specified drug-related sexual adverse events compared with 2.1% on placebo.
Are finasteride side effects permanent?
Persistent sexual symptoms after discontinuation have been reported and are included in U.S. postmarketing labeling. However, because postmarketing reports come from a population of uncertain size, they cannot reliably establish the frequency of persistent symptoms or prove causality in every case.
Do finasteride side effects go away after stopping?
Many sexual adverse effects resolved after discontinuation in clinical trials, and most also resolved among men who continued treatment. Persistent symptoms have nevertheless been reported after stopping.
Does finasteride cause erectile dysfunction?
Finasteride can cause erectile dysfunction. In the pivotal 1 mg trials, erectile dysfunction was reported in 1.3% of finasteride users compared with 0.7% receiving placebo during year one.
Does finasteride lower libido?
It can. Decreased libido occurred in 1.8% of men taking 1 mg finasteride versus 1.3% receiving placebo in first-year clinical-trial data.
Does finasteride reduce semen volume?
It can. Decreased ejaculate volume is a recognized adverse effect. The prescribing information cites a study in which 1 mg finasteride produced a median decrease in ejaculate volume of approximately 0.3 mL after 48 weeks.
Can finasteride affect fertility?
Finasteride may reduce sperm counts or semen quality in some men. A study of men evaluated for infertility found substantial sperm-count improvement in most affected men after discontinuation. Postmarketing labeling also reports male infertility and poor seminal quality, with improvement or normalization reported after stopping in some cases.
Does topical finasteride have side effects?
Yes. Topical finasteride can cause local effects and can still be systemically absorbed. A phase III trial found substantially lower plasma exposure and less serum DHT reduction with topical than oral finasteride, suggesting lower systemic exposure, but not zero exposure.
Is topical finasteride safer than oral finasteride?
Some evidence suggests certain topical formulations produce substantially lower systemic exposure than oral finasteride. However, this does not establish that every topical product is safer or that systemic adverse effects are impossible. Formulation and dose matter.
What are finasteride 1 mg side effects?
The main adverse effects identified in clinical trials were decreased libido, erectile dysfunction, and ejaculation disorder. Postmarketing reports include additional sexual, reproductive, breast, allergic, and psychiatric effects.
What are finasteride 5 mg side effects?
In BPH studies, sexual effects were prominent, including impotence, decreased libido, decreased ejaculate volume, and ejaculation disorders. Breast tenderness and enlargement were also reported.
Are finasteride 5 mg side effects worse than 1 mg?
You cannot reliably answer that by directly comparing the percentages from the major 1 mg hair-loss trials with 5 mg BPH trials because the populations, ages, indications, and study designs differed. Higher-dose BPH studies reported higher first-year sexual adverse-event percentages, but this does not establish an individual's dose-specific risk.
Can women take finasteride?
Finasteride 1 mg is not indicated for use in women in the United States. It has been used off-label in selected women under specialist care, but pregnancy is a major safety concern because finasteride can interfere with normal development of male fetal genitalia.
What are the side effects of finasteride in females?
Safety considerations include the medication's antiandrogenic mechanism and particularly its fetal risk during pregnancy. Finasteride is not indicated for women in current U.S. 1 mg labeling, and pregnant women or those who may become pregnant should not handle crushed or broken tablets.
Can finasteride cause depression?
Depression has been reported with finasteride and appears in U.S. postmarketing information. European regulators also strengthened warnings about mood changes and suicidal ideation associated with oral finasteride.
Can finasteride cause suicidal thoughts?
In 2025, the European Medicines Agency concluded after an EU-wide safety review that suicidal ideation should be recognized as an adverse effect of oral finasteride 1 mg and 5 mg. Its frequency could not be estimated from the available data.
Does finasteride cause low testosterone?
Finasteride primarily inhibits conversion of testosterone into DHT rather than directly suppressing testosterone production. Sexual symptoms during treatment therefore should not automatically be interpreted as testosterone deficiency.
Can TRT prevent finasteride sexual side effects?
There is not good evidence supporting routine TRT as a preventive treatment for finasteride sexual side effects. TRT should be reserved for appropriately evaluated men with a clinical indication for testosterone replacement.
Is dutasteride safer than finasteride?
Current evidence does not establish dutasteride as universally safer. Comparative studies have generally found similar adverse-event rates, although evidence is limited and the medications have different pharmacology.
Can you reduce finasteride side effects?
The first steps are appropriate patient selection, correct diagnosis, discussion of baseline sexual and mental health, consideration of fertility goals, using medication as prescribed, and reporting new symptoms. There is no proven supplement regimen that reliably prevents finasteride adverse effects.
Should I stop taking finasteride if I have side effects?
Do not make prescription changes solely from general online advice. Contact the prescribing clinician about significant sexual or other adverse effects. For oral 1 mg finasteride used for hair loss, current EMA guidance advises stopping and seeking medical advice if depression, depressed mood, or suicidal ideation develops.
The Bottom Line on Finasteride Side Effects
Finasteride is an effective medication for many men with androgenetic alopecia, but it is not free of potential adverse effects.
The strongest controlled evidence shows a small but measurable increase in sexual adverse effects with 1 mg finasteride compared with placebo.
In the pivotal hair-loss trials, one or more drug-related sexual adverse events occurred in 3.8% of men taking finasteride versus 2.1% receiving placebo. Decreased libido, erectile dysfunction, and ejaculation disorders were the principal events.
For many men who experienced sexual adverse effects in clinical trials, symptoms resolved either after discontinuation or even while treatment continued.
However, persistent sexual symptoms after discontinuation have also been reported and are recognized in postmarketing labeling. The existence of these reports should be taken seriously, but available postmarketing data cannot tell us precisely how frequently persistent symptoms occur or establish that finasteride caused every reported case.
Mood effects deserve particular attention. Following a comprehensive safety review, European regulators confirmed suicidal ideation as an adverse effect of oral finasteride while noting that its frequency remains unknown.
Topical finasteride may reduce systemic exposure compared with oral treatment, but it should not be marketed or understood as having zero systemic absorption or zero risk.
The appropriate question is therefore not:
"Is finasteride completely safe?"
or:
"Is finasteride too dangerous for anyone to use?"
A more useful question is:
Do the potential benefits outweigh the potential risks for this individual after considering the diagnosis, treatment goals, sexual health, mental health, fertility plans, alternatives, and personal preferences?
That decision is best made with accurate information and individualized medical guidance rather than fear, marketing claims, or anecdotal reports alone.
Primary Medical Sources
U.S. DailyMed, Finasteride 1 mg Prescribing Information, including controlled-trial adverse-event rates, postmarketing sexual dysfunction, fertility reports, psychiatric reports, pregnancy precautions, and PSA information. (DailyMed)
European Medicines Agency, Finasteride and Dutasteride Safety Review, 2025, including updated recommendations regarding suicidal ideation and mood changes. (European Medicines Agency (EMA))
Topical Finasteride Phase III Randomized Controlled Trial, including systemic exposure and serum DHT findings. (PubMed)
Systematic Review and Meta-Analysis of Sexual Adverse Effects of 5-Alpha-Reductase Inhibitors for Androgenetic Alopecia, including finasteride relative-risk data. (PubMed)
Finasteride in the Male Infertility Population, including changes in sperm counts after discontinuation. (PubMed)
Finasteride vs. Dutasteride Systematic Review and Meta-Analysis, including comparative sexual adverse-event findings. (PubMed)
Medical Disclaimer: This article is for educational purposes only and does not provide individualized medical advice. Do not start, stop, or change a prescription medication based solely on information in this article. Discuss medication risks, side effects, fertility concerns, and treatment alternatives with a qualified healthcare professional.